Scribd Logo
Upload

Welcome to Scribd!

  • 14 views

    Enfermedad Pulmonar Obstructiva Cronica

    Uploaded by

    Charla
    Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease characterized by persistent airflow limitation and respiratory symptoms. It is caused by anomalies of the respiratory airways and alveoli due to factors such as smoking, air pollution, occupational exposures, biomass combustion and genetic conditions. Diagnosis involves spirometry to demonstrate airflow obstruction that is not fully reversible. Treatment focuses on smoking cessation, vaccinations, bronchodilators, anti-muscarinics, corticosteroids and supplemental oxygen for patients with low blood oxygen levels.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Enfermedad Pulmonar Obstructiva Cronica

    Uploaded by

    Charla
    14 views13 pages
    Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease characterized by persistent airflow limitation and respiratory symptoms. It is caused by anomalies of the respiratory airways and alveoli due to factors such as smoking, air pollution, occupational exposures, biomass combustion and genetic conditions. Diagnosis involves spirometry to demonstrate airflow obstruction that is not fully reversible. Treatment focuses on smoking cessation, vaccinations, bronchodilators, anti-muscarinics, corticosteroids and supplemental oxygen for patients with low blood oxygen levels.

    Original Description:

    Original Title

    ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA.pptx

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease characterized by persistent airflow limitation and respiratory symptoms. It is caused by anomalies of the respiratory airways and alveoli due to factors such as smoking, air pollution, occupational exposures, biomass combustion and genetic conditions. Diagnosis involves spirometry to demonstrate airflow obstruction that is not fully reversible. Treatment focuses on smoking cessation, vaccinations, bronchodilators, anti-muscarinics, corticosteroids and supplemental oxygen for patients with low blood oxygen levels.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    14 views13 pages

    Enfermedad Pulmonar Obstructiva Cronica

    Uploaded by

    Charla
    Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease characterized by persistent airflow limitation and respiratory symptoms. It is caused by anomalies of the respiratory airways and alveoli due to factors such as smoking, air pollution, occupational exposures, biomass combustion and genetic conditions. Diagnosis involves spirometry to demonstrate airflow obstruction that is not fully reversible. Treatment focuses on smoking cessation, vaccinations, bronchodilators, anti-muscarinics, corticosteroids and supplemental oxygen for patients with low blood oxygen levels.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    of 13

    ENFERMEDAD PULMONAR

    OBSTRUCTIVA CRONICA

    MIP KARLA CORTÉS


    DEFINICION

    • ENFERMEDAD FRECUENTE, PREVENIBLE Y TRATABLE ANOMALIAS DE VIAS


    RESPIRATORIAS O ALVEOLARES
    • SINTOMAS RESPIRATORIOS
    • vias aereas pequeñas
    • LIMTACION DEL FLUJO AEREO PERSISTENTE • destruccion del parenquima

    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    ETIOLOGIA

    CONTAMINACION EXPOSICION COMBUSTIBLES


    TABAQUISMO
    ATMOSFERICA LABORAL BIOMASA

    GENETICA HIPERSENSIBILIDAD MAL DESARROLLO


    INFECCIONES
    AAT DE VA PULMONAR

    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    DIAGNOSTICO

    DIFERENCIAL:
    • ASMA
    • INSUFICIENCIA CARDIACA CONGESTIVA
    • BRONQUIECTASIAS
    • TB
    • BRONQUIOLITIS OBLITERANTE

    Gold Initiative for Chronic Obstructive Lung Disease. Global


    Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report
    (2017)
    EVALUACION Y CLASIFICACION

    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    ESPIROMETRIA

    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    RX DE TORAX
    TRATAMIENTO

    • MEDIDAS EN TTO
    • DEJAR DE FUMAR
    • VACUNAS
    • ANTIGRIPAL
    • NEUMOCOCICA (REDUCE NEUMONIA)
    • BRONCODIL NO DE ACCION CORTA (LABA (SALMETEROL Y
    FORMOTEROL 2XDIA))
    • ANTIMUSC TIOTROPIO
    • METILXANTINAS
    • CORTICOESTEROIDES
    Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic
    Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
    EPOC ESTABLE
    National Institute for Clinical Excellence. Chronic obstructive pulmonary disease. Management of chronic obstructive
    pulmonary disease in adults in primary and secondary care. Quick reference guide 2004.

    OXIGENO

    • Pacientes con paO2 <55 mmHg respirando aire


    ambiente
    • paO2 entre 56 y 59 mmHg con signos de HTP
    • Insuficiencia cardiaca congestiva
    • Arritmias
    • Edema periférico
    • Hematocrito mayor al 55%.

    • La ATS/ERS3 y la NICE4 recomiendan su


    administración en pacientes
    • Desaturaciones nocturnas >30% del sueño

    You might also like